Tom Amick, has 30 years experience with J&J where he spent most of his career in Ortho Biotech as a senior executive. Most recently he served as VP of Business development for Johnson & Johnson's Development Corporation (JJDC). Tom is an active Board member of emerging life science companies such as Biolex, Stemco (Chairman) among others.

Jack Blair, M.B.A., was President of Smith & Nephew Richards Inc. and member of the Board of Smith & Nephew from 1989 to 1998, time at which he retired from the company. Jack presently serves as non-executive Chairman of dj Orthopedics, Inc., and as a director of NuVasive, Inc and Buckman Laboratories.

Spencer Brown, Ph.D., is Director of Research of the Plastic Surgery Deptartment at UTSW. Prior to this, he served on NHLBI Study Sections. Dr. Brown established new clinical and basic research programs in LDL metabolism at Duke University. Dr. Brown received his PhD from the University of Pennsylvania and completed a postdoctoral fellowship at the at the Baylor College of Medicine.

Gregory Mossinghoff recently retired as President of Inspire Pharmaceuticals where he negotiated and closed the company's six major corporate partnership agreements and various license agreements totaling more than $150M in stated value. Prior to joining Inspire, Mr. Mossinghoff was Worldwide Director of Business Analysis at Glaxo Wellcome, after holding management positions of increasing responsibility positions at Roche Holding Ltd.

Rick Randall, joined TranS1 as full time CEO in June 2002. Previously, Mr. Randall founded and served as President and CEO of Incumed, Inc., a medical device incubator. He also served as President and CEO of the sports medicine firm, Innovasive Devices, Inc., and was President, Chairman and Director of Target Therapeutics, Inc., a medical device company that pioneered the minimally invasive, interventional neurosurgery market.

Carl Simpson, has 40 years of medical device experience and currently is leading Coronis Medical Ventures, a medical device incubator. He was a founder of ACS (acquired by Eli Lilly in 1984 and eventually became Guidant). Mr. Simpson is an active medical device executive andentrepreneur who has served as Director for 16 medical device companies. He also previously worked with Versant Ventures.

Hadley Callaway, M.D., holds a medical doctor degree from Harvard Medical School. His area of expertise is orthopedic surgery, an area where he performs both as a surgeon and a researcher. Dr. Callaway serves as an advisor to Affinergy for matters related to orthopedic devices and practices.

Stephen Cook, Ph.D., is Professor of Orthopedic Surgery and Director of Orthopedic Research at Tulane University School of Medicine. He has deep expertise in conducting pre-clinical studies relating to BMP (Bone Morphogenic Proteins) and works as a consultant for several large companies. He has been active advisor and Board member of several small medical device companies.

William Costerton, Ph.D., is the Director of the Center for Biofilm Engineering at Montana State University. His expertise lies is in immunology and microbiology, with a particular focus on the biology of bacterial biofilms and their development on the surface of biomedical devices.

Farshid Guilak, Ph.D., is an Associate Professor of Surgery and Director of Research for the Division of Orthopaedic Surgery at Duke University Medical Center. He serves as co-Director of Duke's Center for Biomolecular and Tissue Engineering.

Peter C. Johnson, M.D., is a reconstructive microsurgeon who co-founded and served as CEO of TissueInformatics, then became CBO and Chief Medical Officer of Icoria (formerly Paradigm Genetics). He subsequently founded and is now President and CEO of Scintellix, LLC. He serves on the Board of Trustees of Carnegie Mellon University, the Pittsburgh Tissue Engineering Initiative and the Tissue Engineering Society, International.

Jeff Lawson, M.D., Ph.D., is an Assistant Professor of Surgery at Duke University with a vascular surgery clinical practice as well as related research programs. Dr. Lawson is a founding member and officer of the Vascular Access Society of the Americas. He earned his Ph.D. and M.D. at the University of Vermont and began his career at Duke in 1992.

Mitchell W. Krucoff, M.D., is a Professor of Medicine, Cardiology at Duke University, the Director of the Cardiovascular Devices Unit at the Duke Clinical Research Institute, and a member of the Circulatory Devices Panel, Center for Devices and Radiological Health at FDA. Dr. Krucoff earned his undergraduate degree from Yale University and his M.D. from George Washington University.

Lee Simon, M.D., is a leading rheumatologist from Harvard Medical School with over 25 years clinical experience at Harvard, Beth Israel Deaconess, and Johns Hopkins University. Most recently he was Division Director of Analgesic, Anti-Inflammatory, and Ophthalmologic Drug Products at the Food and Drug Administration for 3 years. He is a principal in a regulatory strategy firm and a medical education firm.

George O'Toole, Ph.D., is an Assistant Professor in the Dept. of Microbiology & Immunology at Dartmouth Medical School, and an adjunct Assistant Professor in the Biology Dept. at Dartmouth College.